Large gap with delayed quotes
|
Last quote
02/28/2026
-
02:00:00
|
Bid
02/27/2026 -
21:59:59
|
Bid Volume |
Ask
02/27/2026 -
21:59:59
|
Ask Volume |
|---|---|---|---|---|
|
132.25
+1.61
(
+1.23% )
|
132.17
|
600 |
132.23
|
200 |
Analysis date: 24.02.2026
Global Evaluation
Neutral
Neutral
The stock is classified in the neutral zone since 26.12.2025.
Interest
Very weak
Very weak
One star since 13.02.2026.
Earnings Rev Trend
Negative
Negative
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 03.10.2025 at a price of 137.03.
Evaluation
Strongly undervalued
Strongly undervalued
Based on its growth potential and our own criteria, we believe the share price is currently undervalued.
MT Tech Trend
Negative
Negative
The dividend-adjusted forty day technical trend is negative since 31.12.2025.
4wk Rel Perf
-3.46%
-3.46%
The four-week dividend-adjusted underperformance versus SP500 is 3.46%.
Sensibility
Middle
Middle
The stock has been on the moderate-sensitivity level since 11.11.2025.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by -0.47%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 2.69%.
Mkt Cap in $bn
13.14
13.14
With a market capitalization >$8bn, NEUROCRINE BIOSCIENCES is considered a large-cap stock.
G/PE Ratio
1.51
1.51
A "Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings" ratio higher than 1.5 indicates that the stock's price presents a discount to growth >40% in this case.
LT P/E
12.42
12.42
The estimated PE is for the year 2029.
LT Growth
18.71%
18.71%
The annualized growth estimate is for the current year to 2029.
Avg. Nb analysts
18
18
Over the last seven weeks, an average of 18 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
80
80
For 1% of index variation, the stock varies on average by 0.80%.
Correlation
0.47
0.47
47.28% of stock movements are explained by index variations.
Value at Risk
25.23
25.23
The value at risk is estimated at USD 25.23. The risk is therefore 19.26%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
02.01.2002
02.01.2002